164 related articles for article (PubMed ID: 18202424)
1. Anti-apoptosis mechanisms in malignant gliomas.
Ziegler DS; Kung AL; Kieran MW
J Clin Oncol; 2008 Jan; 26(3):493-500. PubMed ID: 18202424
[TBL] [Abstract][Full Text] [Related]
2. Molecularly targeted therapies for malignant gliomas: advances and challenges.
Penas-Prado M; Gilbert MR
Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
[TBL] [Abstract][Full Text] [Related]
3. Molecularly targeted therapy for malignant glioma.
Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
[TBL] [Abstract][Full Text] [Related]
4. Emerging targeted treatments for malignant glioma.
Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
[TBL] [Abstract][Full Text] [Related]
5. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
6. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
7. Novel targeted pro-apoptotic agents for the treatment of prostate cancer.
Huang X; Zhang X; Farahvash B; Olumi AF
J Urol; 2007 Nov; 178(5):1846-54. PubMed ID: 17868738
[TBL] [Abstract][Full Text] [Related]
8. The potential for strategies using micronutrients and heterocyclic drugs to treat invasive gliomas.
Rooprai HK; Christidou M; Pilkington GJ
Acta Neurochir (Wien); 2003 Aug; 145(8):683-90. PubMed ID: 14520549
[TBL] [Abstract][Full Text] [Related]
9. Promising new therapies for malignant gliomas.
Fine HA
Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
[TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
12. p53 mutant human glioma cells are sensitive to UV-C-induced apoptosis due to impaired cyclobutane pyrimidine dimer removal.
Batista LF; Roos WP; Kaina B; Menck CF
Mol Cancer Res; 2009 Feb; 7(2):237-46. PubMed ID: 19208740
[TBL] [Abstract][Full Text] [Related]
13. Malignant glioma progression and nitric oxide.
Lam-Himlin D; Espey MG; Perry G; Smith MA; Castellani RJ
Neurochem Int; 2006 Dec; 49(8):764-8. PubMed ID: 16971023
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for malignant gliomas.
Kreisl TN
Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
[TBL] [Abstract][Full Text] [Related]
15. Effects of simulated microgravity on proliferation and chemosensitivity in malignant glioma cells.
Takeda M; Magaki T; Okazaki T; Kawahara Y; Manabe T; Yuge L; Kurisu K
Neurosci Lett; 2009 Sep; 463(1):54-9. PubMed ID: 19628020
[TBL] [Abstract][Full Text] [Related]
16. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL
Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183
[TBL] [Abstract][Full Text] [Related]
17. [Histological and molecular classification of gliomas].
Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
[TBL] [Abstract][Full Text] [Related]
18. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in gliomas: molecular mechanisms and therapeutic implications.
Steinbach JP; Weller M
J Neurooncol; 2004 Nov; 70(2):245-54. PubMed ID: 15674481
[TBL] [Abstract][Full Text] [Related]
20. Autophagy: a strategy for malignant gliomas' resistance to therapy.
Ge P; Luo Y; Fu S; Ji X; Ling F
Med Hypotheses; 2009 Jul; 73(1):45-7. PubMed ID: 19268486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
